f.chowdhury
TL2 · Konya
Contributes reviews on supplier material. Based in Konya.
Joined 24 September 2025 · last posted 2d · groups: regional-apac
81Posts here
0Topics
1Solutions
1.4kLikes received
1.9kLikes given
19Badges
207Days visited
4.9kPosts read
Recent activity
Full stream-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #100 · Practice › Dosing & titration · 26 Jul 2026 · 27 likes Confirming post #97 from a second method, which matters more than confirming it from a second person. There is no published evidence about slower escalation because…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #16 · Compounds › Tirzepatide · 23 Jul 2026 · 21 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
Publication patterns in the BPC-157 literature, examined Replied, post #42 · Compounds › Repair & healing peptides · 22 Jul 2026 · 16 likes On post #38 — agreed on the reasoning, with one qualification. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
Common supplements people ask about, assessed one at a time Replied, post #59 · Practice › Interactions · 17 Jul 2026 · 32 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist. That…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #32 · Compounds › Repair & healing peptides · 15 Jul 2026 · 2 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Journal club: what we got wrong in an earlier session Replied, post #70 · Evidence › Journal club · 10 Jul 2026 · 0 likes I read post #67 twice before replying, because I had assumed the opposite. Where the group cannot agree, record the disagreement rather than resolving it by seniority.…
-
Tracking a shortage from primary sources rather than rumour Replied, post #85 · Access › Shortages · 5 Jul 2026 · 2 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated.
-
Journal club: LEADER as the historical anchor Replied, post #99 · Evidence › Journal club · 4 Jul 2026 · 5 likes Post #98 answers the question as asked. The question underneath it is different. The figures usually contain the finding and the text usually contains the…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #16 · Analytics › Mass spectrometry · 4 Jul 2026 · 27 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
How to ask a question when you cannot say why you are asking it Replied, post #30 · Start Here › How to Ask · 4 Jul 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
A structured critique template this community uses — a second dataset Replied, post #25 · Evidence › Study critique · 1 Jul 2026 · 7 likes A critique should end with what would change your mind. Without that it is a position rather than an argument. For what it is worth, the same held on the two occasions…
-
Alcohol: what is documented and what is folklore Replied, post #87 · Practice › Interactions · 1 Jul 2026 · 33 likes A supplement is a drug for interaction purposes, and the fact that it is sold without a prescription tells you nothing about whether it interacts. The paperwork is…